Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PACRG antisense RNA 1 (PACRG-AS1) is a long noncoding RNA gene transcribed in the opposite direction to the PACRG gene. It is considered a natural antisense transcript (NAT), a class of RNAs that may regulate gene expression through base-pairing interactions with sense transcripts or modulate chromatin structure, but no specific molecular functions or clinical implications have yet been attributed to PACRG-AS1 in scientific literature[6][1]. PACRG-AS1 is annotated in genomic databases, including GeneCards, but detailed data on its expression profile, regulatory functions, or disease involvement remains unavailable. Further studies are required to clarify its role in physiology or pathology.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PACRG antisense RNA 1 (non-protein coding) (PACRG-AS1).